3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
57
Carcinoma, Non-Small-Cell Lung
34
Urinary Bladder Neoplasms
29
Neoplasm Metastasis
20
Lung Neoplasms
19
Ovarian Neoplasms
18
Lymphoma, Large B-Cell, Diffuse
18
Cholangiocarcinoma
15
Biliary Tract Neoplasms
14
Triple Negative Breast Neoplasms
13
Neoplasms
13
Nasopharyngeal Carcinoma
13
Colorectal Neoplasms
12
Breast Neoplasms
12
Carcinoma, Transitional Cell
11
Non-Muscle Invasive Bladder Neoplasms
10
Recurrence
9
Fallopian Tube Neoplasms
9
Gallbladder Neoplasms
8
Sarcoma
6
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Bile Duct Neoplasms
6
Osteosarcoma
5
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Endometrial Neoplasms
5
Uterine Cervical Neoplasms
4
Melanoma
4
Hodgkin Disease
4
Colonic Neoplasms
4
Interventions
Cyclophosphamide
32
Vincristine
22
blinatumomab
20
Methotrexate
20
Specimen Handling
19
Prednisone
19
Cytarabine
17
merphos
16
prednylidene
15
deltacortene
15
Biopsy
15
Mercaptopurine
14
Doxorubicin
14
Dexamethasone
14
N,N-dicyclohexyl-isoborneol-10-sulfonamide
13
pegaspargase
12
azathiopurine
12
Rituximab
12
Etoposide
12
dexamethasone acetate
11
dexamethasone 21-phosphate
11
auricularum
11
Spinal Puncture
11
Calcium Dobesilate
11
Asparaginase
11
Leucovorin
10
fludarabine
9
Magnetic Resonance Spectroscopy
9
Inotuzumab Ozogamicin
9
Daunorubicin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Burkitt Lymphoma
×
Gemcitabine
×
90 days
×
Clear all
No trials found.